抗CD38单抗治疗多发性骨髓瘤的抗体鉴定策略
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

常州市青年科技人才项目( QN202133) ;常州市中心血站科研基金(XZ202 107 ) ;常州市科技局项目( CJ20220240)


Strategies for identification of antibody in multiple myeloma patients treated with anti-CD38 MoAb
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘要:目的分析经抗 CD38单抗治疗的多发性骨髓瘤患者的抗体并探索鉴定策略。方法选取2019年11月至2021年6月用抗CD38单抗治疗且配血不合的30例多发性骨髓瘤患者作为研究对象。用0.2 mol/L二硫苏糖醇(DTT)处理的谱细胞对患者血清标本进行抗体特异性鉴定;对有自身抗体的患者用血清倍比稀释法鉴别同种抗体及自身抗体;于第1.7.14.28 .35天监测DTT处理后的红细胞在生理盐水和血型分析用稀释液中的游离血红蛋白浓度。结果用 DTT处理的谱细胞鉴定发现,24例均为阴性;1例检出抗E同种抗体合并自身抗体;5例检出自身抗体。利用倍比稀释法确认,4例自身抗体没有特异性,1例检出类抗C自身抗体。生理盐水组与血型分析用稀释液组游离血红蛋白浓度随贮存时间延长不断上升,两组差异有统计学意义(P<0.05)。结论经抗 CD38单抗治疗的多发性骨髓瘤患者,建议用DTT处理的谱细胞合并血清倍比稀释法快速初 步鉴别同种抗体、自身抗体以及CD38单抗干扰;血型分析用稀释液可以用于保存DTT处理的谱细胞。

    Abstract:

    Abstract: Objective To analyze the antibodies in the multiple myeloma patients treated with anti-CD38 MoAb antibodies and explore the strategies for identification of antibodies. Methods A total of 30 patients with multiple myeloma who were treated with anti-CD38 MoAb and exhibited crossmatching incompatibility from November 2019 to June 2021 were selected as the study subjects. 0.2 mol/L dithiothreitol ( DTT) -treated profiling cells were used to identify the specificity of various antibodies in the studied serum samples. The serum of the patients with autoantibodies were identified by multiple dilution method. The concentrations of free hemoglobin in normal saline and diluent for blood group analysis were monitored on the day 1, 7, 14, 28 and 35. Results The identification for profiling cells treated with DTT revealed that none was detected as positive antibodies in the 24 cases. Anti-E alloantibodies combined with autoanti- bodies were detectable in 1 case. Autoantibodies were detectable in 5 cases who were conformed by diluted serum. Among them, 4 cases showed no andibody-related specificity, and one mimicked the specifcity of anti-C antibody. The concentrations of free hemoglobin in both saline group and diluent group showed increased trend with the prolongation of storage time, but the difference between the two groups showed statistically significant. Conclusion DTT-treated spectrum cells combined with serum dilution method can be used to identify the alloantibodies ,autoantibodies quickly and easily in the multiple myeloma patients who were treated with anti-CD38 MoAb.The diluents for blood group analysis can be used to preserve the DTT- treated spectrum cells.

    参考文献
    相似文献
    引证文献
引用本文

邹昕,范小杰,虞茜,许飞,杨红梅.抗CD38单抗治疗多发性骨髓瘤的抗体鉴定策略[J].临床检验杂志,2023,41(01):56-59

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-12-16
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-05-22
  • 出版日期:
您是第位访问者  苏ICP备12051282号-1
主管单位:江苏省医学会  出版单位:临床检验杂志
单位地址:江苏省南京市中央路42号  邮编:210008
电话:025-83620683 E-MAIL:lcjyzz@163.com
技术支持:北京勤云科技发展有限公司